Skip to main content
. 2024 Jan 30;12(1):E155–E163. doi: 10.1055/a-2240-0678

Table 2 EUS-TA results in relation to biochemical analysis and McH results.

EUS-TA N %
EUS-TA, endosonography-guided tissue acquisition; McH, microhistology; CEA, carcinoembryonic antigen; MN, mucinous cystic neoplasia; n-MN, non-mucinous cystic neoplasia; PP, pancreatic pseudocyst; CA,cancer antigen.
Cystic fluid number (%) 57 39.3
Cystic fluid, median (range) mL 14.1 (2–150)
CEA (ng/mL), n 54 94.7
> 192 (MN detected) 22 40.7
5–192 (Inconclusive) 19 35,3
< 5 (n-MN detected) 13 24
CA19.9 (U/mL), n 52 91.2
> 140.000 (MN detected) 7 13.4
< 140.000 (inconclusive) 45 86.5
Amylase (U/L) 53 93
< 250 (no PP) 15 28.3
> 250 (PP? or MN) 38 71.7
Glucose (mg/dL) 20 35
< 50 (MN detected) 10 50
> 50 (n-MN detected) 10 50